ADAR1 Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$676K	Buy	275,800 +34,000	+14%	+$83.3K	0.1%	96
2025 Q1	$1.61M	Buy	241,800 +30,400	+14%	+$203K	0.3%	61
2024 Q4	$2.66M	Buy	211,400 +207,100	+4,816%	+$2.6M	0.53%	40
2024 Q3	$79.4K	Buy	4,300 +4,200	+4,200%	+$77.6K	0.01%	183
2024 Q2	$2.15K	Buy	+100	New	+$2.15K	﹤0.01%	235